Clinical Trials Directory

Trials / Completed

CompletedNCT03257085

CALIBER Phase 1: A Pilot Study in Normal-weight and Overweight Adults.

CALIBER (Carbohydrates, Lipids and Biomarkers of Traditional and Emerging Cardiometabolic Risk Factors) Phase 1: A Pilot Study in Normal-weight and Overweight Adults.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Liverpool John Moores University · Academic / Other
Sex
All
Age
19 Years – 64 Years
Healthy volunteers
Accepted

Summary

Pilot study to compare the impact of following a low-carbohydrate, high-fat diet versus following a high-carbohydrates, moderate-fat diet (UK dietary guidelines) on cardiometabolic risk markers and associated behaviours in a normal-weight and overweight adult population.

Detailed description

Cardiometabolic diseases (CMD), such as type 2 diabetes and cardiovascular disease (CVD), are globally amongst the highest contributors to morbidity and mortality with high (cost) implications to the overall economy and health care systems. A number of risk markers have been associated with CMDs, including blood serum markers, low levels of lean mass and high levels of body fat, including increased waist circumference. Dietary factors and nutritional status have long been linked with specific markers of cardiometabolic (CM) risk. The quantity and quality of dietary carbohydrates has been associated with increased serum triglycerides levels, increased body fat mass, increased waist circumference and visceral fat around the organs in particular. They also seem to increase food cravings. Whilst official dietary guidelines in the UK and elsewhere still recommend a high carbohydrate and low fat diet as standard, these recommendations have increasingly been challenged. Evidence has been mounting that very-low carbohydrate (ketogenic) and low carbohydrate diets can ameliorate CM risk factors, especially when a personalised rather than a one-size-fits-all approach is being taken. Response to carbohydrate load and adherence to dietary interventions can vary widely dependent on individual substrate and energy metabolism and insulin-resistant status. The majority of dietary interventions with ketogenic and low-carbohydrate diets has focused on weight loss as the primary outcome in overweight and obese individuals. However, in recent years evidence has been mounting that the location and quality of adipose tissue (AT) play a more important role in manifestation of CM risk than quantity of AT alone. Detrimental health behaviours, such as low-quality diet and low levels of physical activity seem to be important contributors to this. Further studies can provide vital insights into the links between diet, location-specific adipose tissue, CM risk factors and health-related behaviours. Therefore this 8-weeks randomised pilot study will investigate the impact of either following a low-carbohydrate, high-fat diet versus following a high-carbohydrates, moderate-fat diet (UK dietary guidelines) on cardiometabolic risk markers and associated behaviours in a normal-weight and overweight adult population aged 19 - 64 at potential risk of CMD.

Conditions

Interventions

TypeNameDescription
OTHERLow-carbohydrate, high-fatParticipants following low-carbohydrate, high-fat diet for 8 weeks.
OTHERHigh-carbohydrate, moderate-fatParticipants following high-carbohydrate, moderate-fat diet (UK dietary guidelines) for 8 weeks.

Timeline

Start date
2017-03-09
Primary completion
2017-12-08
Completion
2017-12-08
First posted
2017-08-22
Last updated
2018-03-08

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03257085. Inclusion in this directory is not an endorsement.